U.S. Stem Cell, Inc.
U.S. Stem Cell, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | |||||||||||||||||
Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | |||||
Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Investments | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | |||||
Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Accounts Payable Current | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Accrued Liabilities Current | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | |||||
Bank Overdrafts | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | |||||
Due To Related Parties Current | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Deferred Gain On Sale Of Property | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Other Liabilities Current | 1 | - | - | - | 1 | - | - | - | - | - | - | - | |||||
Deferred Revenue Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | |||||
Liabilities Current | |||||||||||||||||
Deposit Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 14 | 14 | 13 | 13 | 12 | 12 | 11 | 11 | 11 | 10 | 10 | 9 | |||||
Notes Payable Related Parties Classified Current | - | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | |||||
Notes Payable | 4 | - | - | - | 3 | - | - | - | - | - | - | - | |||||
Long Term Debt And Capital Lease Obligations Curre… | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 1 | 1 | 1 | |||||
Notes Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Convertible Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Noncurrent | |||||||||||||||||
Liabilities Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Deferred Revenue Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Long Term Notes Payable | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities | 15 | 14 | 14 | 14 | 13 | 12 | 12 | 12 | 12 | 11 | 10 | 10 | |||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | -15 | -14 | -14 | -13 | -13 | -12 | -12 | -11 | -12 | -11 | -10 | -10 | |||||
Additional Paid In Capital | 127 | 127 | 127 | 127 | 127 | 126 | 126 | 126 | 124 | 124 | 124 | 124 | |||||
Retained Earnings Accumulated Deficit | -143 | -142 | -141 | -141 | -140 | -139 | -138 | -137 | -137 | -136 | -135 | -134 | |||||
Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | |||||
Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | |||||
Debt Instrument Unamortized Discount | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Debt Instrument Unamortized Discount Current | - | 0 | 0 | 0 | - | - | - | - | - | - | - | - | |||||
Debt Instrument Unamortized Discount Noncurrent | 0 | - | - | - | 0 | - | - | - | 0 | - | - | - | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | |||||
Common Stock Shares Issued | 634 | 632 | 598 | 592 | 504 | 461 | 452 | 450 | 436 | 430 | 428 | 425 | |||||
Shares Outstanding | 634 | 632 | 598 | 592 | 504 | 461 | 452 | 450 | 436 | 430 | 428 | 425 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | -16.13% | -12.90% | -1.77% | 19.01% | -17.36% | -12.40% | -19.23% | -7.69% | -13.46% | -16.67% | -39.90% | -30.56% |
| 2021 | 0.54% | 0.00% | -5.38% | 0.00% | -5.38% | -11.54% | -28.33% | -50.00% | -41.67% | -22.87% | -28.72% | -44.68% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.02 | 0.06 | 0.01 | 0.01 | 0.02 | 0.01 | |||||
| Quick Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.05 | 0.01 | 0.01 | 0.02 | 0.01 | |||||
| Working Capital | -14.01M | -13.46M | -13.10M | -12.60M | -11.99M | -11.55M | -11.09M | -10.32M | -10.76M | -10.35M | -9.36M | -9.08M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.00 | -1.01 | -1.01 | -1.01 | -1.00 | -1.01 | -1.02 | -1.06 | -1.01 | -1.01 | -1.02 | -1.01 | |||||
| Interest Coverage TTM | -2.49 | -1.68 | -1.80 | -2.16 | -2.14 | -3.49 | -4.33 | -4.25 | -4.91 | -6.06 | -8.46 | -5.26 | |||||
| Debt Ratio | 217.72 | 83.62 | 195.93 | 94.90 | 251.33 | 153.41 | 60.82 | 18.35 | 132.36 | 95.65 | 50.98 | 105.69 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 1.38 | 0.68 | 0.95 | 0.36 | 2.89 | 2.94 | 1.49 | 0.83 | 3.11 | 1.22 | 1.04 | 2.70 | |||||
| Days Sales Outstanding TTM | 12.33 | 81.30 | 59.57 | 145.56 | 50.34 | 35.22 | 34.25 | 85.51 | 67.43 | 16.17 | 11.18 | 10.00 | |||||
| Receivables Turnover TTM | 29.59 | 4.49 | 6.13 | 2.51 | 7.25 | 10.36 | 10.66 | 4.27 | 5.41 | 22.57 | 32.66 | 36.50 | |||||
Per Share Metrics | |||||||||||||||||
| Free Cash Flow Per Share TTM | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 71.03% | 67.93% | 71.72% | 68.61% | 74.08% | 81.55% | 80.54% | 79.75% | 76.86% | 52.55% | 39.19% | 54.35% | |||||
| Operating Profit Margin TTM | -2,096.90% | -1,994.81% | -1,411.34% | -1,548.79% | -1,063.94% | -756.86% | -901.34% | -786.00% | -866.24% | -604.60% | -613.23% | -193.08% | |||||
| Net Profit Margin TTM | -3,483.21% | -3,422.93% | -2,360.60% | -2,479.60% | -1,637.58% | -1,106.54% | -1,240.78% | -1,083.79% | -1,043.17% | -632.64% | -616.38% | -205.27% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -59.13% | -70.71% | -57.05% | -54.05% | -27.55% | -37.87% | -46.72% | -83.31% | -90.98% | -89.37% | -90.26% | -71.08% | |||||
| Net Income Growth (1Y) | -13.06% | -9.39% | -18.28% | 5.13% | 13.73% | 8.67% | 7.25% | -11.86% | -24.64% | -17.38% | 51.50% | 38.72% | |||||
| EPS Growth (1Y) | -31.00% | -33.90% | -38.28% | -19.99% | -1.62% | 1.25% | 1.61% | -16.85% | -27.72% | -23.52% | 39.36% | 27.21% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -1.07 | -1.32 | -1.10 | -1.61 | -0.92 | -1.58 | -1.87 | -6.84 | -1.84 | -0.62 | -0.74 | -0.78 | |||||
| P/B TTM | -0.21 | -0.27 | -0.24 | -0.42 | -0.24 | -0.41 | -0.59 | -2.02 | -0.46 | -0.17 | -0.25 | -0.30 | |||||
| P/S TTM | 37.11 | 45.02 | 26.01 | 39.83 | 15.05 | 17.51 | 23.21 | 74.09 | 19.18 | 3.93 | 4.56 | 1.61 | |||||
| Market Cap | 3.05M | 3.86M | 3.35M | 5.56M | 3.02M | 5.12M | 6.96M | 22.52M | 5.31M | 1.85M | 2.57M | 2.93M | |||||
| Enterprise Value | 11.99M | 8.87M | 8.38M | 10.63M | 11.00M | 9.90M | 11.65M | 26.88M | 10.06M | 5.37M | 6.02M | 6.35M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -304.85K | -478.49K | -619.82K | -804.23K | -1.06M | -962.27K | -952.01K | -701.74K | -478.89K | -577.71K | -837.29K | -965.24K | |||||
| Net Debt | 8.94M | 5.02M | 5.03M | 5.06M | 7.98M | 4.78M | 4.69M | 4.36M | 4.74M | 3.53M | 3.45M | 3.42M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
U.S. Stem Cell, Inc. (USRM) — SEC Financial Statements & Analysis
U.S. Stem Cell, Inc. (USRM) is a services-commercial physical & biological research company, incorporated in FL. U.S. Stem Cell, Inc. trades on OTC as: USRM. Based on its latest SEC filing (Form 10-Q, period ending 2022-12-31), U.S. Stem Cell, Inc. reported a -59.13% year-over-year revenue growth, a Gross Profit Margin of 71.03% (TTM), a Debt-to-Equity ratio of -1.00x, a Price-to-Sales (P/S) ratio of 37.11x (TTM), a Price-to-Book (P/B) ratio of -0.21x (TTM), at a market cap of $3.05M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -59.13%
- Gross Profit Margin TTM
- 71.03%
- Debt To Equity
- -1.00x
- P/S TTM
- 37.11x
- P/B TTM
- -0.21x
- Market Cap
- $3.05M
Data as of 2022-12-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is U.S. Stem Cell, Inc. in?
U.S. Stem Cell, Inc. (USRM) operates in the Services-Commercial Physical & Biological Research industry.
What is USRM's market cap?
U.S. Stem Cell, Inc. (USRM) has a market capitalization of $3.05M as of 2022-12-31.
What exchange does USRM trade on?
U.S. Stem Cell, Inc. (USRM) trades on the OTC.
Where is U.S. Stem Cell, Inc. incorporated?
U.S. Stem Cell, Inc. is incorporated in FL.